EndoChoice

📍 Alpharetta, United States🗓 Founded 2008👥 80 employees💰 Last funded 2012
Medical Equipment Manufacturing🌐 endochoice.com
Website LinkedIn
Based near Atlanta, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists diagnosing and treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 25 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®).
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in EndoChoice?
EndoChoice has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did EndoChoice last raise funding?
The most recent investment in EndoChoice recorded on gritt.io was in 2012.
When was EndoChoice founded?
EndoChoice was founded in 2008.
What industry is EndoChoice in?
EndoChoice operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is EndoChoice based?
EndoChoice is headquartered in Alpharetta, United States.